drugset / Trial / NCT00226317

Aripiprazole in the Treatment of Bipolar Depression

NCT00226317

NaSingle-groupOpen-labelTreatment

Summary

A systematic open-label prospective pilot study to assess aripirazole for acute bipolar depression, with a secondary assessment of longer-term mood stabilization.

Timeline

Start
2004-04
Primary completion
2007-12
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified

Indications